Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07778472Phase 1Completed
Phase 1, randomised, double-blind trial of tripelennamine in pruritus (3 arms), sponsored by Palm Beach Atlantic University. Primary endpoint: Visual Analog Scale for Itch Intensity. Started Feb 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07778472.